Dr. Patel on the Potential With PARP/Immunotherapy Combos in NSCLC
Dr. Patel on the Potential With PARP/Immunotherapy Combos in NSCLC
2021年7月30日
onclive.com
Dr Goldsberry on PARP Inhibitor Selection in Advanced Ovarian Cancer
Dr Goldsberry on PARP Inhibitor Selection in Advanced Ovarian Cancer
3 周前
onclive.com
Dr Garje on Selecting Between PARP Inhibitor Combinations in mCRPC
Dr Garje on Selecting Between PARP Inhibitor Combinations in mCRPC
9 个月之前
onclive.com
Dr Lattanzi on the Investigation of PARP Inhibitor Combinations in mCRPC
Dr Lattanzi on the Investigation of PARP Inhibitor Combinations in mCRPC
9 个月之前
onclive.com
Impact of Frontline PARP Inhibitor Approvals on Treatment Decisions for Newly Diagnosed Advanced Ovarian Cancer
Impact of Frontline PARP Inhibitor Approvals on Treatment Decisions for Newly Diagnos…
1 个月前
vumedi.com
Recurrent Ovarian Cancer: PARP Inhibitor Maintenance Therapy
Recurrent Ovarian Cancer: PARP Inhibitor Maintenance Therapy
2019年4月29日
onclive.com
Dr Crane on the Ongoing Investigation of PARP Inhibitor Combinations in Ovarian Cancer
Dr Crane on the Ongoing Investigation of PARP Inhibitor Combinations in Ovarian C…
8 个月之前
onclive.com
Recent Updates in PARP Inhibitor Indications for Ovarian Cancer
2022年10月6日
onclive.com
Duration of PARP Inhibitor Maintenance Therapy for Ovarian Cancer
3 个月之前
onclive.com
0:55
穷小子意外获得超能力，单凭意念就能瞬移世界各地 2/3
1 周前
qq.com
PARP Inhibitor Side Effect Management in Ovarian Cancer
2017年12月23日
onclive.com
ESGO 2024 Insights: "PARP Inhibitor Resistance Mechanisms in Gynecologic Ca…
已浏览 171 次10 个月之前
vumedi.com
Guideline recommendations for first-line treatment intensification with PARP inhibit…
1 个月前
reachmd.com
[Hot Item] Phosphorus Based Zinc Corrosion Inhibitor Synthetic Metal Working Cutting F…
3 个月之前
made-in-china.com
Dr. Willmott on Using Genetic Testing to Inform PARP Inhibitor Selection in Ovarian …
2021年7月29日
onclive.com
Dr Gong on the Benefits and Limitations of PARP Inhibitor–Based Regimens in mCRPC
6 个月之前
onclive.com
Improving Interprofessional Management and Clinical Outcomes with PARP Inhibitors fo…
6 个月之前
reachmd.com
0:37
PARP2 antibodies from Thermo Fisher Scientific
2023年2月12日
thermofisher.com
PARP Inhibitors in Pancreatic Cancer
2016年7月20日
onclive.com
Synthetic Lethality: outmaneuvering the cancer genome | GSK US
2022年7月20日
gsk.com
An Update on the PARP Inhibitor Olaparib in mCRPC Patients: Review of the Phase 2 Re…
4 个月之前
urotoday.com
Future of PARP Inhibitors in mCRPC
2017年6月26日
onclive.com
Evolving Role of PARP Inhibitors in Ovarian Cancer
2017年12月23日
onclive.com
PARP Inhibitors and Indications in Ovarian Cancer
2019年10月24日
onclive.com
Case: A Patient With High-Risk HR /HER2- EBC Potentially Eligible for CDK4/6 and/or …
4 个月之前
reachmd.com
Sequencing PARP Inhibitors in Advanced Ovarian Cancer
2019年4月29日
onclive.com
Dr. Birrer on PARP Inhibitors in Ovarian Cancer
2018年3月29日
onclive.com
PARP Inhibition’s Role in Recurrent Ovarian Cancer
2020年5月27日
onclive.com
Role of PARP Inhibitors in Prostate Cancer
2019年7月31日
onclive.com
Lethality Bioassay Using Artemia salina L.
已浏览 7296 次3 个月之前
jove.com
观看更多视频
静态缩略图占位符
反馈